StockData
Panacea Life Sciences Holdings, Inc. logo

Panacea Life Sciences Holdings, Inc. (PLSH) stock

PLSHOTCMedicinal Chemicals & Botanical ProductsFiscal year ends December 31
Financials through Q1 FY2024, quarter ended Mar 31, 2024Last filing: 10-Q on May 6, 2024
$0.07+0.00 (+5.45%)

Close on Oct 19, 2026Market cap $1.15MP/E –Yield –

Panacea Life Sciences total assets

Total assets on the balance sheet at the end of each period.

Panacea Life Sciences's total assets was $17.41M at Mar 31, 2024. For fiscal 2023 it was $17.98M, down 7.7% from the year before. The highest annual figure on record is $31.36M in fiscal 2020.

Annual total assets

PeriodPeriod endValueChange
FY2023Dec 31, 2023$17.98M-7.7%
FY2022Dec 31, 2022$19.49M-18.1%
FY2021Dec 31, 2021$23.78M-24.2%
FY2020Dec 31, 2020$31.36M+291.2%
FY2019Dec 31, 2019$8.02M+56001.0%
FY2018Dec 31, 2018$14.29K-91.7%
FY2017Dec 31, 2017$172.67K-91.9%
FY2016Dec 31, 2016$2.13M+2403.5%
FY2015Dec 31, 2015$84.89K+0.1%
FY2014Dec 31, 2014$84.81K–

Quarterly total assets

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q1 FY2024Mar 31, 2024$17.41M-6.2%
Q4 FY2023Dec 31, 2023$17.98M-7.7%
Q3 FY2023Sep 30, 2023$18.73M-6.3%
Q2 FY2023Jun 30, 2023$17.85M-18.7%
Q1 FY2023Mar 31, 2023$18.56M-17.2%
Q4 FY2022Dec 31, 2022$19.49M-18.1%
Q3 FY2022Sep 30, 2022$19.98M-17.3%
Q2 FY2022Jun 30, 2022$21.97M-18.0%
Q1 FY2022Mar 31, 2022$22.41M+38499.0%
Q4 FY2021Dec 31, 2021$23.78M-24.2%
Q3 FY2021Sep 30, 2021$24.17M+678.0%
Q2 FY2021Jun 30, 2021$26.78M+344.1%
Q1 FY2021Mar 31, 2021$58.06K-99.1%
Q4 FY2020Dec 31, 2020$31.36M+291.2%
Q3 FY2020Sep 30, 2020$3.11M-67.6%
Q2 FY2020Jun 30, 2020$6.03M-6.2%
Q1 FY2020Mar 31, 2020$6.75M+14.7%
Q4 FY2019Dec 31, 2019$8.02M+56001.0%
Q3 FY2019Sep 30, 2019$9.59M+73208.3%
Q2 FY2019Jun 30, 2019$6.43M+7789.1%
Q1 FY2019Mar 31, 2019$5.89M+6793.8%
Q4 FY2018Dec 31, 2018$14.29K-91.7%
Q3 FY2018Sep 30, 2018$13.08K-98.8%
Q2 FY2018Jun 30, 2018$81.45K-92.5%
Q1 FY2018Mar 31, 2018$85.44K-93.8%
Q4 FY2017Dec 31, 2017$172.67K-91.9%
Q3 FY2017Sep 30, 2017$1.05M-2.9%
Q2 FY2017Jun 30, 2017$1.09M+0.3%
Q1 FY2017Mar 31, 2017$1.37M+353.8%
Q4 FY2016Dec 31, 2016$2.13M+2403.5%
Q3 FY2016Sep 30, 2016$1.08M+3658.2%
Q2 FY2016Jun 30, 2016$1.09M+1183.8%
Q1 FY2016Mar 31, 2016$302.09K–
Q4 FY2015Dec 31, 2015$84.89K–
Q3 FY2015Sep 30, 2015$28.86K–
Q4 FY2014Dec 31, 2014$84.81K–

More Panacea Life Sciences figures

See a number that looks wrong?